posted
NOVM Novamex USA .63 and ONLY 10.5 Million shares. Had base around .25, in Sept shot up to .98 then drifted down and has been in the .4-.6 range, now up to .63 As I write this, the TV is blaring out about a case of Mad Cow Disease showing up today. NOVM has acquired the WORLD WIDE PATENT on a prion test for MAD COW DISEASE. The disease is produced by prions, tiny protein molecules that produce diseases that attack the brain tissue, including mad cow disease. the disease is produced by eating infected meat. One thing that I have not seen any newspaper or magazine mention, is that some of the natives of Borneo that would eat the brains of dead relatives as part of their burial rites had a large percentage of the population dying from human spongiform encephalopathy, the human form of mad cow disease. And now that I snuck that into this discussion, I can say that it is relevent because NOVM is developing a test that can be done on living people to see if they have the disease. But besides that, they already have a test that CAN BE USED NOW to test living cattle on site for Mad Cow Disease and they are the only company with such a test. Their stock looks like has broken out of its base and so now might be a good time to buy it. So grab the bull by the horn (as long as it doesn't have mad cow disease) and go for it.
IP: Logged |
posted
I tried to buy the stock this morning with my Scottrade account, since I had some spare money in it, but they wouldn't allow me to but it because they don't keep bid/asks on it
IP: Logged |
quote:Originally posted by STAR GAZER: I tried to buy the stock this morning with my Scottrade account, since I had some spare money in it, but they wouldn't allow me to but it because they don't keep bid/asks on it
posted
is there a place to get more info on this company. Their info on the Pink sheet is thin. and I have only seen 2002 SEC fileings. I'm going to call them tomarrow.
IP: Logged |
posted
I called them today. Mostly speak French up there. They do have a Madcow test. They have run one trial test and are now doing the second one. They gave me the # to someone else. Richard Diotte 418-527-3362. He is going to call me back.
IP: Logged |
posted
Accoding to the newpaper, the Red Cross does not accept blood donations from people that have been to countries that have had a mad cow disease incident, such as England. But now we have had an incident. Of course, they could say that it was just an isolated incident and that the cow came from Canada. But that might not go over too well with the public or government officials. So it seems to me that they are going to have to start testing blood for mad cow disease, and if they choose Novamex's test, then the stock could REALLY TAKE OFF. In fact, it has already started climbing. Closed Friday at .79 (56 Ford, I hope that you were able to buy some at .70 or .71)
IP: Logged |
posted
They did not call me back. I got cold feet. Was in @ .71 Out @ .79. If it is like evertime before, it will double this next month. Took the money for LBTT for under .02 hope to triple to make up for it.
Star I'm in. Any thoughts VITX @.94 1/4 of my $ ththf @.002 big way tfct @.05 big way MSGL @.195 I'm sell on bounces in on dip BUGS will get out after it comes up RNKE I'm out at the moment but will get back in on dip
posted
Talked to Richard on monday. He said they they will be ready to turn their test over to the Canada AG department for testing in march. They want to start there then the USDA will be next. I got back in @.75 a little, Of course it went down. I most likely will start accummalating this at any thing under the .75
IP: Logged |
posted
Star I just found this at Pinksheets.com. I take it that they got the $5 mil and the stocks really have to go about $1.00 before he really makes money. #2 the inventors are covering the pattins ownership. What are your thoughts.
NOVM -- Novamex USA Ltd. Com (No Par)
Company News and Press Releases From Other Sources:
Novamex USA Ltd. Receives $5,000,000 Financing Package Subscription Agreement for its BSE - Mad Cow Disease - Test
VILLE SAINT-LAURENT, Quebec, Dec 31, 2003 (BUSINESS WIRE) -- Novamex USA Ltd. (Pink Sheets: NOVM) is pleased to announce that it has received a subscription agreement from a private trust company for a $5,000,000 financing package. The Investor has agreed to subscribe to a 5 year convertible debenture paying an annual interest of 7%, and convertible into common stock of Novamex USA Ltd. at a price of $1.00 per share. These funds will enable the company to complete staffing requirements and to validate and commercialize its ante mortem diagnostic test kit for BSE . The closing of the subscription is expected to take place on February 16, 2004 Novamex also wishes to report that a Canadian law firm has been appointed to oversee and execute the legal transfer of the worldwide patent no. PCT/FR 02/0078, which was acquired September 3, 2003 from Doctors Jacques A. Mayet and Louis Lery.
Patent no. PCT/FR 02/00728 covers a unique testing procedure for a protein (prion) which has been used to develop a test for Bovine Spongiform Encephalopathy, commonly known as "Mad Cow Disease". Unlike existing tests, this test can be performed on living animals.
Under the agreement for the acquisition of the patent, a payment of $50,000 USD has been made and a total of 6,000,000 restricted shares of NOVAMEX USA Ltd. have been issued in favour of Drs. Mayet and Lery.
Novamex USA Ltd. is in the process of having its SEC filings brought up to date. This step will allow the Company to apply for a listing on the OTC BB.
Novamex USA Ltd. is a publicly traded company, currently listed on the Pink Sheets under the symbol NOVM.
posted
I first looked at this stock early last year when we had the SARS scare. Their stock has been STEADLY CLIMBING, but I never invested in it because I haven't quite uderstood what they do. It is true that they investigate disease processes and come up with ways to fight different types of diseases, but I'm not sure if they make their own drugs. From what I can see, they reccommend ACE inhibitors to fight disease such as SARS and they say what type and quantity to use, but other companies make and sell ACE inhibitors, so I am not sure how they would make money on their insights, however, their stock is low priced and has been steadly climbing, so it may be a very good buy.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
